Tag: AML
March 6, 2019
Bio-Path Announces Clinical Update to Interim Analysis of Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia
Bio-Path Holdings (NASDAQ:BPTH) has announced a clinical update on its interim analysis from the Phase 2 trial of prexigebersen (BP1001)... May 22, 2018